Enbrel 25 MG/0.5 ML vial 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FR1PF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,656
Award facts
- Contract value 100% obligated
- $26,656.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $26.7K delivery order to AmerisourceBergen Drug Corp for the supply of Enbrel 25 mg/0.5 mL vials under a firm fixed price contract. The award, issued on October 21, 2025, with an ultimate completion date of October 22, 2025, represents a continuation of pharmaceutical procurement through the agency's medical supply chain. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania.
This award is a child contract executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion vehicle running through December 2026 that provides global pharmaceutical support for military healthcare programs. Enbrel, a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis and other inflammatory conditions, is part of the extensive pharmaceutical portfolio AmerisourceBergen supplies to support Defense Health Agency operations and other federal healthcare systems. The contract demonstrates the company's established capability to fulfill federal medical procurement requirements for specialty medications within compressed timeframes.
Quick answers
Who was awarded contract SPE2DB26FR1PF?
SPE2DB26FR1PF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 21, 2025.
How much is contract SPE2DB26FR1PF worth?
The government has obligated $26,656 on SPE2DB26FR1PF.
Is contract SPE2DB26FR1PF an order under another contract?
Yes. SPE2DB26FR1PF is a delivery order under SPE2DB22D2218, an indefinite delivery contract.
Was contract SPE2DB26FR1PF competed?
The extent of competition for SPE2DB26FR1PF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award